Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 1, Open-Label, Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects with Advanced Solid Tumors and Subsequent Expansio
Sponsored by Promontory Therapeutics
Active
$735.4K Funding
4 People
External
Related Topics
cancer,
pharmacokinetics,
clinical effects,
intravenous administration,
safety
People
AJ Steuer
(CD)
Cancer Center Division
﹒Research Compliance Administrator I
Edward Gelmann
Co-Investigator (COI)
Medicine
﹒Professor
Alejandro Recio Boiles
Principal Investigator (PI)
Medicine
﹒Assistant Professor, Medicine - (Clinical Scholar Track)
Brianna Denton
(CD)
Cancer Center Division
﹒Research Compliance Manager I